Eden Research Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Oxford, Oxfordshire and currently employs 23 full-time employees. The company went IPO on 2012-05-11. The firm develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products include crop protection, animal health, and consumer products. Its crop protection includes Mevalone and Cedroz. Mevalone is a foliar, contact biofungicide which delivers a controlled release pattern of multiple terpene active ingredients. Cedroz is a terpene-based product developed in conjunction with Eastman Chemical Company as a post-planting solution to the problem of root-knot nematodes. The firm's Sustaine encapsulation technology is used to harness the biocidal activity of naturally occurring molecules produced by plants (terpenes) as part of their defence systems. Sustaine is used in a wide range of applications such as agricultural, animal health and consumer products
How did EDNSF's recent EPS compare to expectations?
The most recent EPS for Eden Research PLC is $, expectations of $.
How did Eden Research PLC EDNSF's revenue perform in the last quarter?
Eden Research PLC revenue for the last quarter is $
What is the revenue estimate for Eden Research PLC?
According to of Wall street analyst, the revenue estimate of Eden Research PLC range from $ to $
What's the earning quality score for Eden Research PLC?
Eden Research PLC has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Eden Research PLC report earnings?
Eden Research PLC next earnings report is expected in 2026-05-31
What are Eden Research PLC's expected earnings?
Eden Research PLC expected earnings is $, according to wall-street analysts.
Did Eden Research PLC beat earnings expectations?
Eden Research PLC recent earnings of $ expectations.